Penn Cancer Network

Comprehensive, Quality Care—Close to Home

Doylestown Hospital is a member of the Penn Cancer Network, a group of select community-based hospitals serving Pennsylvania, New Jersey and Delaware that collaborate and consult with specialists and researchers from Penn Medicine's Abramson Cancer Center. The Abramson Cancer Center is one of the nation's foremost cancer centers and provides subspecialty care that is typically unavailable at the local level. It is one of a few cancer centers in the country designated by the National Cancer Institute as a Comprehensive Cancer Center.

As a member of the Penn Cancer Network since 1992, the Cancer Institute of Doylestown Hospital offers high quality care and advanced treatment options at the hospital’s main campus or locally accessible outpatient facilities. While most treatments can be provided effectively and appropriately at Doylestown Hospital, our affiliation with Penn Medicine offers access to cutting-edge therapies and innovative clinical trials available no where else in the region. This collaborative and integrated system of care benefits local residents of Bucks and Montgomery counties and nearby communities in the Philadelphia northern suburbs and central New Jersey.

Local Services and Coordinated Care for Best Outcomes

Our board-certified hematologists, oncologists, surgeons, cancer specialists, certified oncology nurse navigators and staff work together with Penn’s team of experts and internationally renowned researchers from the Abramson Cancer Center. Most patients receive all of their care at Doylestown Hospital; however, for patients who receive care at Penn, the Penn specialists remain in close contact with the patient's local physicians assuring optimal, comprehensive and coordinated care.

Doylestown Hospital’s membership in the Penn Cancer Network offers benefits for patients including:

  • Vast resources and technological expertise, including direct and local access to cutting-edge treatments and innovative clinical trials through the Abramson Cancer Center. 
  • Genetic risk evaluation and assessment in collaboration with the Abramson Cancer Center’s Cancer Risk Evaluation Program (CREP). This program is for men and women who want information about their personal risk for breast, ovarian and gastrointestinal cancers, including colon cancer.
  • Penn Radiation Oncology Doylestown, an outpatient radiation treatment program located on Doylestown Hospital’s campus. This satellite location features board-certified radiation oncologists, a state-of-the-art linear accelerator and advanced therapies including Image-Guided Radiation Therapy (IGRT) and Intensity-Modulated Radiation Therapy (IMRT). Our specialists refer directly to Penn for highly specialized treatments including proton therapy, Gamma Knife® and CyberKnife®.
  • The Abramson Cancer Center’s educational and support programs to address key areas of concern for cancer patients, families and caregivers. Many of Penn’s innovative patient education programs have been recognized by national groups, including the National Cancer Institute's Cancer Patient Education Network. These programs are available in addition to the many community-based educational and support groups available at Doylestown Hospital.
  • Electronic medical records, which provide a seamless transition between facilities should a patient require treatment at Penn Medicine.